Patents by Inventor Thao-Vi Dao

Thao-Vi Dao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230087609
    Abstract: The invention relates to a pharmaceutical composition comprising one or more stimulators of soluble guanylate cyclase (sGC), or a combination of at least one stimulator of sGC and at least one activator of sGC, for use in a method of treatment of a disease and/or a disorder that is/are associated with a deficiency of cyclic 3?,5?-guanosine monophosphate in the patient to be treated. The invention also relates to a therapeutic combination comprising a first unit dose comprising an sGC stimulator and a second unit dose comprising an sGC activator. The invention also relates to a therapeutic combination comprising a first unit dose comprising a first sGC stimulator and a second unit dose comprising a second sGC stimulator, for use in a method for the treatment of a disease and/or a disorder that is/are associated with a deficiency of cyclic 3?,5?-guanosine monophosphate in the patient to be treated.
    Type: Application
    Filed: February 18, 2021
    Publication date: March 23, 2023
    Applicants: Universiteit Maastricht, Academisch Ziekenhuis Maastricht
    Inventors: Harald Horst Heinz Wilhelm Schmidt, Mahmoud Hassan Mahmoud Elbatrik, Thao-Vi Dao, Ana Isabel Casas Guijarro, Theodora Saridaki, Alexandra Petraina